Loading clinical trials...
Loading clinical trials...
The Impact of Infant and Maternal Immunoprophylaxis on Hospitalisation for Respiratory Syncytial Virus in the Australian Capital Territory: A Population-based Interrupted Time Series Study
Conditions
Locations
1
Australia
The Canberra Hospital
Garran, Australian Capital Territory, Australia
Start Date
September 22, 2025
Primary Completion Date
January 31, 2026
Completion Date
January 31, 2026
Last Updated
March 5, 2026
NCT06998251
NCT07071558
NCT07128121
NCT07177508
NCT05639894
NCT02718937
Lead Sponsor
Nicola Irwin
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions